9th Microbiome Movement Drug Development Summit

Temas de la conferencia
As landmark Ferring and Seres Therapeutics approvals prove the safety of the microbiome modality, robust clinical efficacy data for disease beyond infectious is now paramount to reinvigorate investment across the community.

The 9th Microbiome Movement Drug Development Summit returns as the industry's trusted, definitive forum for the global network of microbial therapeutic developers.

Organizador profesional (PCO)
Hanson Wade

Observaciones
URL:
Brochure: https://go.evvnt.com/2317343-3?pid=4832

Speakers: Ada Lam, Research Analyst, Beacon Microbiome, Adam Harvey, Associate Director - Clinical Research, Global Clinical and Translational Sciences, Ferring Pharmaceuticals, and more

https://go.evvnt.com/2317343-2?pid=4832

Ms. Nandita Iyer